Hypertrophy, Right Ventricular
"Hypertrophy, Right Ventricular" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Enlargement of the RIGHT VENTRICLE of the heart. This increase in ventricular mass is often attributed to PULMONARY HYPERTENSION and is a contributor to cardiovascular morbidity and mortality.
MeSH Number(s)
C14.280.195.410
C23.300.775.250.401
Concept/Terms
Hypertrophy, Right Ventricular- Hypertrophy, Right Ventricular
- Ventricular Hypertrophy, Right
- Right Ventricular Hypertrophy
- Hypertrophies, Right Ventricular
- Right Ventricular Hypertrophies
- Ventricular Hypertrophies, Right
Below are MeSH descriptors whose meaning is more general than "Hypertrophy, Right Ventricular".
Below are MeSH descriptors whose meaning is more specific than "Hypertrophy, Right Ventricular".
This graph shows the total number of publications written about "Hypertrophy, Right Ventricular" by people in Harvard Catalyst Profiles by year, and whether "Hypertrophy, Right Ventricular" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 0 | 1 |
| 1994 | 3 | 0 | 3 |
| 1995 | 2 | 0 | 2 |
| 1996 | 1 | 1 | 2 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 1 | 2 |
| 2000 | 1 | 2 | 3 |
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2004 | 2 | 2 | 4 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 2 | 3 | 5 |
| 2008 | 2 | 2 | 4 |
| 2009 | 2 | 0 | 2 |
| 2010 | 1 | 0 | 1 |
| 2011 | 2 | 0 | 2 |
| 2012 | 2 | 0 | 2 |
| 2013 | 2 | 1 | 3 |
| 2014 | 3 | 1 | 4 |
| 2015 | 4 | 2 | 6 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 0 | 2 |
| 2018 | 1 | 2 | 3 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 1 | 2 |
| 2022 | 0 | 2 | 2 |
Below are the most recent publications written about "Hypertrophy, Right Ventricular" by people in Profiles.
-
Endothelin B Receptor Immunodynamics in Pulmonary Arterial Hypertension. Front Immunol. 2022; 13:895501.
-
Vascular smooth muscle ROCK1 contributes to hypoxia-induced pulmonary hypertension development in mice. Biochem Biophys Res Commun. 2022 05 14; 604:137-143.
-
Impact of early sports specialisation on paediatric ECG. Scand J Med Sci Sports. 2021 Jun; 31(6):1335-1341.
-
MicroRNA-21 regulates right ventricular remodeling secondary to pulmonary arterial pressure overload. J Mol Cell Cardiol. 2021 05; 154:106-114.
-
The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertension. Biochem Biophys Res Commun. 2020 03 26; 524(1):50-56.
-
Preoperative Predictors of Death and Sustained Ventricular Tachycardia After Pulmonary Valve Replacement in Patients With Repaired Tetralogy of Fallot Enrolled in the INDICATOR Cohort. Circulation. 2018 11 06; 138(19):2106-2115.
-
Is there any diagnostic value of anteroposterior chest radiography in predicting cardiac chamber enlargement? Int J Cardiovasc Imaging. 2019 Jan; 35(1):195-206.
-
Branch Pulmonary Artery Valve Implantation Reduces Pulmonary Regurgitation and Improves Right Ventricular Size/Function in Patients With Large Right Ventricular Outflow Tracts. JACC Cardiovasc Interv. 2018 03 26; 11(6):541-550.
-
Cardiopulmonary Exercise Testing in Patients Following Massive and Submassive Pulmonary Embolism. J Am Heart Assoc. 2018 03 03; 7(5).
-
Mother With Diabetes Mellitus and Infant With Hypertrophic Obstructive Cardiomyopathy: Milrinone Precluded Need for Extracorporeal Membrane Oxygenation. Circ Cardiovasc Imaging. 2017 11; 10(11).